Literature DB >> 31148344

Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process.

Dorota Kopciuch1, Tomasz Zaprutko1, Anna Paczkowska1, Piotr Ratajczak1, Łucja Zielińska-Tomczak2, Krzysztof Kus1, Elżbieta Nowakowska1.   

Abstract

PURPOSE: Patients' safety is a public concern in healthcare systems across the world and should be ensured, among others, by pharmacovigilance based on spontaneous reports of adverse drug reactions (ADRs). Spontaneous ADRs reporting is an important component of the pharmacovigilance system. The role of pharmacists in spontaneous ADRs reporting is crucial in the pharmacovigilance system since it helps to monitor the patients' treatment in real-life conditions. The aim of the study was to evaluate the pharmacists' attitudes to and knowledge on spontaneous ADRs reporting in Poland and to identify the reasons for underreporting of ADRs.
METHODS: The study was conducted between January 2016 and January 2018. A self-administered questionnaire was designed and distributed to pharmacists. The pharmacists were randomly selected from the official database kept by the chief pharmaceutical inspectorate in Poland.
RESULTS: Only 16% (n = 84) of the respondents have ever attended a training on pharmacovigilance. Eighty-one percent (N = 422) of pharmacists believe that not all synthetic drugs available on the market were safe. Twenty-eight percent (n = 146) of the respondents were certain about safety of drugs of natural origin, and 16% (n = 84) were of an opinion that adverse reactions following administration of such drugs should not be reported at all.
CONCLUSIONS: To conclude, there is an increasing awareness of the need to develop pharmacovigilance practices. The current (not fully adhered to in practice) model of pharmacovigilance and its associated tools have been developed for synthetic drugs, and applying these methods to monitor safety of herbal medicines presents unique challenges.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  adverse drug reactions; pharmacists' behavior; pharmacists' knowledge; pharmacoepidemiology; pharmacovigilance; safety of medicines

Year:  2019        PMID: 31148344     DOI: 10.1002/pds.4792

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  5 in total

1.  Knowledge, Attitude and Practice of Hospital Pharmacists in Central China Towards Adverse Drug Reaction Reporting: A Multicenter Cross-Sectional Study.

Authors:  Wen Hu; Yun Tao; Yun Lu; Suyu Gao; Xuanxuan Wang; Wenjing Li; Qiaoli Jiang; Likai Lin; Feng Sun; Hong Cheng
Journal:  Front Pharmacol       Date:  2022-03-22       Impact factor: 5.810

2.  Neurologists' Knowledge, Practice, and Attitudes towards Pharmacovigilance and Adverse Drug Reactions Reporting Process in Epileptic Patients-Comparative Analysis from Poland and Egypt.

Authors:  Dorota Kopciuch; Nashwa Nabil Kamal; Nashaat Nabil Kamal; Nermin Aly Hamdy; Anna Paczkowska; Tomasz Zaprutko; Piotr Ratajczak; Jędrzej Fliciński; Krzysztof Kus; Elżbieta Nowakowska
Journal:  Int J Environ Res Public Health       Date:  2022-03-31       Impact factor: 3.390

Review 3.  Adverse drug reaction management in hospital settings: review on practice variations, quality indicators and education focus.

Authors:  Ar Kar Aung; Steven Walker; Yin Li Khu; Mei Jie Tang; Jennifer I Lee; Linda Velta Graudins
Journal:  Eur J Clin Pharmacol       Date:  2022-02-16       Impact factor: 2.953

4.  Spontaneous adverse drug reaction reporting by community pharmacists: preparedness and barriers.

Authors:  Mohamed Bahlol; Mary Bushell; Hani M J Khojah; Rebecca Susan Dewey
Journal:  Saudi Pharm J       Date:  2022-04-19       Impact factor: 4.562

5.  Hepatotoxicity associated with the use of teriflunomide in a patient with multiple sclerosis: A case report.

Authors:  Cristiane Munaretto Ferreira; Erica Freire de Vasconcelos-Pereira; Vanessa Marcon de Oliveira; Pedro Rippel Salgado; João Américo Domingos; Maria Tereza Ferreira Duenhas Monreal; Elvira Maria Guerra-Shinohara; Vanessa Terezinha Gubert
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.